Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate
Clinical trial NCT00374842 · COMPLETED
Trial details
- NCT number
- NCT00374842
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-03
- Primary completion
- 2006-11-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.